Camurus CEO Fredrik Tiberg on Long-Acting Opioid Treatment
Turning Generics Into Game-Changing Therapies: Fredrik Tiberg of Camurus Explains the Power of Long-Acting Medicines...
Fredrik Tiberg, Camurus 🇸🇪 | Opioid Crisis, Long-Acting Injections | E51
Founded in 1991, Camurus has grown into a $4B biotech with two products in the...
The 25 Most Valuable Biotech Companies in Europe in 2025
The biotech industry in Europe is booming, with companies making groundbreaking medical advances, from oncology...
Never Miss a New Episode 💌
Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.
Watch & Subscribe
